Long-term outcomes of Sleeping Beauty generated CD19specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.
暂无分享,去创建一个
D. Marin | E. Shpall | Y. Nieto | U. Popat | M. Qazilbash | A. Alousi | W. Wierda | H. Huls | R. Champlin | K. Rezvani | L. Cooper | C. Hosing | P. Kebriaei | H. Kantarjian | S. Srour | H. Singh | J. McCarty | E. de Groot | G. Rondon | S. Ciurea | G. Bardelli | J. Buck